Stocks

The SEC has ordered a halt to the High Times IPO after the company missed its annual report deadline in June; recent marketing material, however, suggests that fundraising efforts are still underway.

Collective Growth Corp., the new hemp investment and acquisition venture headed by veteran cannabis CEO Bruce Linton, raised $150 million in its recent IPO.

Cannabis companies are paying insurance rates that are up to seven times higher than other industries with many citing a rise in U.S. lawsuits against publicly traded cannabis firms.

The Dixie Elixirs brand in Colorado — one of the cannabis industry’s most established edibles brands — announced it would change its name to drop the historically racist term “Dixie.”

Florida-based Jushi Inc. is set to acquire Vireo Health International’s cultivation-processor facilities in Pennsylvania in a $37 million deal.

Toronto-based Halo Labs, which serves consumers in both Canada and multiple U.S. state markets, reported a 49 percent decrease in revenue during the first quarter of 2020.

MedMen’s embattled co-founders Andrew Modlin and Adam Bierman have stepped down from their roles on the company’s board of directors.

Florida medical cannabis company Bluma Wellness Inc. is now trading on the Canadian Securities Exchange under the BWEL.U symbol.

Cresco Labs has appointed Michele Roberts, head of the NBA Players Association, to its board of directors; she is the first woman and person of color appointed to the company’s board.

Hightimes Holding Corp. announced a partnership with Red, White & Bloom to create High Times-branded dispensaries and develop cannabis products in Michigan, Illinois, and Florida.

Vireo Health has terminated its employment of veteran cannabis executive Bruce Linton.

Denver-based Schwazze is set to acquire 14 Star Buds locations throughout Colorado including 13 dispensaries and one cultivation site.

FSD Pharma has received FDA permission to design and submit an application for a new trial using a synthetic cannabinoid-based drug in the treatment of COVID-19.

Florida MCBD is suing New York-based Columbia Care claiming a pattern of wrongful interference as Columbia worked to secure a Florida cannabis business license.

Harborside in California is continuing its challenge of the federal tax code 280E, which the company’s legal team says is unconstitutional and runs afoul of the 16th Amendment.

The Maine Cannabis Coalition is suing the state over its recent decision to remove residency requirements for cannabis licensees.

A recent survey suggests that cannabis companies with the highest-paid executives tended to underperform over the last year compared to the industry average.

CannTrust has had the licenses for one of its grow facilities reinstated after its federal licenses were suspended last year over multiple regulatory violations.

Protests over the police killing of George Floyd took place nationwide over the weekend; in California, cannabis dispensaries were wrecked and looted, including Cookies and several MedMen locations.

Canadian cannabis producer Tilray has announced it will close its 406,000 ft greenhouse in Leamington, Ontario.

Aurora Cannabis announced it will acquire U.S. hemp CBD company Reliva in a $40 million all-stock deal.

Artemis Growth Partners has agreed to the $81 million acquisition of Bridge Farm Group, the UK’s leading ornamental plant, flower, and herb producer.

A recent SEC filing shows that Hightimes Holding Corporation has extended its Regulation A fundraising after a unanimous board decision for an 11-for-1 stock split beginning June 1.

Amid international shakeups, major alcohol distributor Constellation Brands has increased its stake in Canopy Growth Corp. by 5.1 percent, bringing its total stake in the company to 38.6 percent.